Genomic Prediction Clinical Laboratory
North Brunswick, New Jersey, 08902, United States
Location status: Recruiting
Location contact
Bhavini Rana
CONTACT
Nathan Treff, PhD
PRINCIPAL_INVESTIGATOR
Talia Metzgar, RN
CONTACT
NCT Number: NCT04477863
The main purpose of this study is to perform longitudinal evaluations of clinical outcomes and personal perspectives following utilization of preimplantation genetic testing (PGT). Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. A licensed genetic counselor will conduct a recorded interview.
Interested in participating?
Request InfoAll sexes
Observational
North Brunswick, New Jersey, 08902, United States
Location status: Recruiting
Bhavini Rana
CONTACT
Nathan Treff, PhD
PRINCIPAL_INVESTIGATOR
Talia Metzgar, RN
CONTACT
Purpose: To perform longitudinal studies of clinical outcomes and personal perspectives following utilization of PGT.
Background: Preimplantation Genetic Testing (PGT) is a commercially available adjunct to in vitro fertilization (IVF) and is now performed in over 40% of treatment cycles in the United Sates (Society for Assisted Reproductive Technology Annual Report, 2018). Several clinical genetics entities offer PGT services, including Genomic Prediction Clinical Laboratory (CLIA# 31D2152380, CAP# 8488628). It is common practice to perform interviews with, and record reviews of patients following clinical interventions. Results may provide instrumental information for the scientific and medical community to improve clinical care. We would like to review medical records in order to recruit patients to participate in longitudinal studies of clinical outcomes and personal perspectives following utilization of PGT.
Study Design and Methods: Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. Patients who opted out of participating in research during informed consent to perform PGT will be ineligible for inclusion. Clinical PGT consent forms will be reviewed to identify patients that indicated willingness to participate in research. Eligible patients will be counseled on the study and consented for participation by a licensed genetic counselor. A total of 10,000 patients will be recruited. Following patient recruitment and informed consent, patient records and results of patient interviews may be used for publication in peer-reviewed scientific journals, presentation at scientific conferences or company meetings. As it is in standard practice, all external communication of results will maintain de-identification of all protected health information of all subjects (HIPAA guidelines). A licensed genetic counselor will conduct a recorded interview. Patient PGT, family history, and ethnicity data and information may be included in cohort analyses.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non Applicable
Time frame: 2 years
Analysis of interview responses
Contact information is provided by the study sponsor or research team.
Bhavini Rana
CONTACT
Talia Metzgar, RN
CONTACT
Genomic Prediction Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06023472
Aneuploidy, Chromosomal Rearrangement
Hong Kong, China
View Trial DetailsNCT01500447
Amenorrhea, Congenital Abnormalities
Bethesda, Maryland, United States
View Trial DetailsNCT05500573
Genital Diseases, IVF
New York, United States
View Trial DetailsNCT07480668
Anxiety, Anxiety Disorders
Belo Horizonte, Minas Gerais, Brazil
View Trial Details